Silica has been used for many years as an agent which selectively alters macrophage functions and, as such, has been used to assess the role of macrophages in the immune response to a variety of microbial and chemically defined agents. Silica treatment of C3H/HeN mice 1 day before challenge with protein-free Escherichia coli endotoxin (lipopolysaccharide [LPS]) resulted in a marked increase in LPS sensitivity, as evidenced by accelerated signs of endotoxemia as well as a fourfold decrease in the LPS 50% lethal dose. The silicamediated increase in responsiveness to LPS was associated with increased production of macrophage-derived soluble factors both in vivo (interferon) and in vitro (Interleukin 1; previously referred to as lymphocyte activating factor or LAF) upon endotoxin stimulation. These findings support the central role of the macrophage and its products in mediating endotoxic reactions.
Although a great deal of circumstantial evidence points to the macrophage as the principal cell type involved in mediating the toxic effects of lipopolysaccharide (LPS) (31) , the lack of a murine model with a severe macrophage deficit analogous to the T-cell deficit in athymic mice has precluded the direct demonstration of macrophage participation in LPS sensitivity. We approached this problem by treating mice with silica, an agent which has been reported to be toxic for macrophages in vivo and in vitro (1, 10, 13, 30) and to result in concomitant reticuloendothelial system dysfunction (9, 14, 15, 19, 35, 36) . Although the precise mechanism(s) by which silica affects macrophage functions has not been elucidated, we reasoned that if silica selectively altered macrophage function and if macrophages were central in mediating endotoxicity, then one would predict that the administration of silica should alter the outcome of an endotoxic challenge.
The results presented in this report demonstrate that the administration of silica to C3H/HeN mice increased their sensitivity to the toxic effects of endotoxin. This enhanced susceptibility to LPS was accompanied by augmented production of two well-characterized, LPS-stimulated, macrophage-derived products, i.e., interferon and Interleukin 1 (IL 1). Thus, these findings indicate an increase in LPS sensitivity at the level of the macrophage and provide further support for the primary role of macrophages and their products in endotoxic reactions.
MATERIALS AND METHODS
Mice. C3H/HeN male or female mice were used throughout this study at 8 to 12 weeks of age. These mice were obtained from either Charles River Breeding Laboratories, Inc. (Wilmington, Mass.) or the Small Animal Section, National Institutes of Health (NIH; Bethesda, Md.). All mice were housed conventionally and fed food and water ad libitum.
Endotoxin. Protein-free Escherichia coli K235 endotoxin was prepared by the method of McIntire et al. (17) .
Treatment of mice with silica. Mice were treated intravenously with silica or diluent as described previously (1, 21) 24 h before challenge with LPS in vivo or before LPS stimulation of peritoneal exudate macrophage cultures in vitro. The silica preparation used in this study was no. 216 Min-u-sil (average size, 1.5 p.m) and was obtained as a gift from Whittacker, Clarke, and Daniels (Plainsfield, N.J.). It was prepared for intravenous injection precisely as described previously (21) .
Assays for LPS sensitivity. (i) Lethality. The indicated doses of LPS in 0.5 ml of pyrogen-free saline were injected intraperitoneally into mice. Deaths were recorded daily for 72 h. The 50o lethal dose for each experiment was calculated by the method of Reed and Muench (22) .
(H) Interferon production and assay. Interferon levels were determined on serum samples collected 2 h after intravenous administration of 10 ,g of LPS as described previously (32) . Antiviral activity was measured by a modification of the method of Rubinstein et al. (24) (iii) IL 1 production and assay. Thioglycolate-induced peritoneal exudate cells were prepared and cultured as described previously (33) . Silica or diluent was administered as previously described (1, 21) to mice 24 h before the preparation of macrophage cultures for subsequent in vitro stimulation with LPS. Differential counts on cytospin preparations of peritoneal exudate cells from silica-or diluent-treated mice were comparable, as were the total numbers of viable macrophages obtained per mouse. Adherent macrophage monolayers (2 x 106 macrophages per well) were prepared in 24-well culture dishes (Costar). Macrophages were stimulated with medium or various concentrations of endotoxin for 48 h. Supernatants were collected, filter sterilized, and assayed in serial dilutions for IL 1 activity in a thymocyte proliferation assay as described previously (18) . Units of IL 1 were determined by linear regression analysis as described previously (29) . A titration of a fresh aliquot of IL 1 standard was included within each assay. The standard used in our laboratory was an IL 1-rich, LPSstimulated, P388D1 macrophage cell line supernatant which was stored in aliquots at -70°C and was arbitrarily assigned a value of 100 U/ml.
RESULTS
Effects of silica administration on LPS-induced lethality. Treatment of C3H/HeN mice with silica before challenge with LPS rendered them more sensitive to the lethal effects of LPS (Fig.  1 ). Mice that received diluent exhibited a 50% lethal dose of 421 jig of LPS, whereas silicatreated mice exhibited a 50% lethal dose of 153 p,g. In addition, both the symptoms which are classically associated with murine endotoxicity (i.e., diarrhea, ruffled fur, conjunctival exudate) and the time of death were accelerated in silicapretreated mice. By 24 h after LPS administration, 62% of deaths within the silica-treated population had occurred compared with 42% in the control population. By 48 h, 90% of deaths among the silica-treated group had occurred compared with 75% in the control group.
Effect of silica on LPS-induced interferon in vivo. A more sensitive measure of in vivo LPS sensitivity is the production of circulating interferon which peaks at approximately 2 h after administration of LPS (34) . This type of interferon has been demonstrated previously to be primarily of macrophage origin (12) . The data in Table 1 demonstrate that mice pretreated with silica produce significantly higher levels of circulating interferon upon challenge with a sublethal dose (10 ,ug) of LPS when compared with the response of diluent-pretreated animals. Silica pretreatment alone did not result in detectable levels of circulating interferon.
When the time between treatment with silica and challenge with LPS was lengthened to 72 h, the magnitude of the augmented interferon response was mitigated ( (1, 21) . One day later, saline or saline containing 10 ,ug of LPS was administered intravenously. Serum samples were collected 2 h later and assayed for interferon (antiviral) activity.
I Each experiment represents the activity contained in serum pools of three mice per treatment group. described previously (1, 21) . When these mice were subsequently challenged with LPS 24 h later, the interferon titers were reduced by approximately twofold in both diluent and silica treatment groups (data not shown). Thus, PVNO failed to reverse specifically the enhancing effect of silica.
Effect of in vivo silica treatment on LPS-induced IL 1 production by peritoneal macrophages in vitro. To further examine the mechanism(s) by which silica treatment renders mice more endotoxin sensitive, the in vitro response of macrophages derived from silica-or diluenttreated mice to LPS was assessed. We chose to measure LPS-induced IL 1 production by macrophages for several reasons. First, IL 1 has been shown in several studies to be closely related to or identical to endogenous pyrogen (20) , a circulating product which has long been associated with in vivo endotoxicity. Second, the ability of IL 1 to induce thymocyte proliferation (as measured by [3H]thymidine incorporation) provides an extremely sensitive and The results in Table 3 demonstrate that macrophages derived from mice pretreated with silica produce significantly more IL 1 than macrophages derived from diluent-treated animals at all concentrations of LPS tested (0.01 to 10 ,ug/ml). These findings demonstrate that silica renders C3H/HeN macrophages more responsive to LPS as assessed by their increased production of IL 1.
DISCUSSION
In this report we have demonstrated that the administration of silica to endotoxin-sensitive mice potentiates their LPS sensitivity in vivo. This increase in LPS sensitivity was accompanied by an enhanced production of interferon in vivo in response to LPS stimulation. In addition, macrophages derived from silica-treated mice produce significantly more IL 1 when stimulated in vitro with LPS. Thus, these findings suggest an increased sensitivity to LPS at the level of the macrophage. B-cell sensitivity to LPS (as assessed by LPS-stimulated [3H]thymidine incorporation in splenic cultures derived from silicapretreated mice) remained at control levels (data not shown), suggesting that the increase in sensitivity to the toxic effects of LPS was not dependent upon B-cell participation. These findings are consistent with those previously reported for the in vivo and in vitro LPS hyperreactivity associated with Mycobacterium bovis BCG administration (28, 32, 33) . Specifically, BCGinfected C3H/HeN mice were found to be approximately eight times more sensitive to the lethal effects of LPS and produced significantly more interferon upon LPS challenge (32) . In addition, macrophages derived from BCG-in- fected C3H/HeN mice also produced significantly more IL 1 and prostaglandin E2 when stimulated with LPS in vitro (33) . As was observed for silica-treated mice, LPS-induced B-cell mitogenesis in spleen cell cultures from BCG-infected animals was normal (unpublished observation). In addition to BCG, a number of other infectious agents have also been shown to cause an increase in LPS responsiveness, e.g., Histoplasma capsulatum, Plasmodium berghei, and Bordetella pertussis. Certain noninfectious agents such as carrageenan, zymosan, and others (4, 6, 16, 27) have also been shown to increase LPS sensitivity in vivo, and treatment of macrophages in vitro with cytokine-rich preparations has been shown to render these cells more LPS sensitive (31) .
The mechanism(s) by which these agents exert their potentiating effects has not yet been elucidated; however, several possible mechanisms are suggested by our findings and those of others. First, the LPS-sensitizing agents may directly or indirectly lead to macrophage membrane perturbations, which in turn, labilize the cell or lower its threshold to respond to LPS with the production of enzymes and monokines normally associated with LPS sensitivity. Support for this hypothesis resides in the findings that agents that stabilize membranes, such as cortisone, ZnC12, and methyl palmitate, increase resistance to LPS challenge in vivo (3, 7, 26) .
The observation that silica enhances LPS sensitivity may be very closely related to the potentiation of endotoxin sensitivity observed with carrageenan (2) and suggests a second possible mechanism. Both substances have been shown to destabilize lysosomal membranes (5, 23) , and their effects on lysosomal disruption can be reversed with agents that stabilize lysosomes, such as PVNO (8, 23) . It is unlikely that the increase in LPS sensitivity which we observed after silica administration is solely related to lysosomal destabilization since PVNO administration before silica treatment failed to reverse significantly the LPS-stimulated increase in interferon titers. However, the membrane-destabilizing effect of silica may not be restricted to lysosomal membranes and may result in a more complete release of LPS-stimulated monokines. This hypothesis is supported by the recent findings of Gery et al. (11) who reported that the in vitro stimulation of macrophages with silica and LPS results in intracellular concentrations of IL 1 equivalent to LPS stimulation alone but greatly elevated levels of extracellular IL 1. However, silica-facilitated release of LPS-induced IL 1 cannot solely account for this, since the total amount of IL 1 (intra-plus extracellular) was significantly greater than the additive sum of either treatment alone. A third possible mechanism for the augmentation of LPS sensitivity by silica is suggested by the previous findings of O'Brien et al. (21) . Following intravenous administration of silica, these investigators found a marked increase in the number of macrophages in the spleen. Greater numbers of recruited macrophages could feasibly underlie an apparent increase in LPS sensitivity by making proportionately more soluble factors. However, this possibility seems less likely in view of our in vitro evidence that cultures containing equal numbers of macrophages derived from peritoneal exudates of silica-treated mice make more IL 1 than control cultures.
The findings in this report support and extend the notion that the macrophage and its products play a central role in mediating the toxic effects of LPS. The use of silica to modulate endotoxin sensitivity is of particular relevance when considered in light of previous findings that silica treatment of mice renders them significantly more susceptible to intraperitoneal infection with Salmonella typhimurium (21) . In that study, the sensitizing effect of silica was reversed with lysosome-stabilizing agents, and the authors concluded that silica-induced destabilization of macrophage lysosomes rendered mice less able to restrict the growth of salmonellae. The finding that silica also renders mice more sensitive to LPS might well provide an additional mechanism by which silica potentiates gramnegative infection. This possibility is compatible with the findings of Senterfitt and Shands (25) that administration of hydrocortisone to LPShyperreactive, BCG-infected mice lengthened the mean time of death and greatly decreased the number of deaths in the first 4 days after Salmonella infection.
